Lentiviral gene delivery of vMIP-II to transplanted endothelial cells and endothelial progenitors is proangiogenic in vivo

Molecular Therapy

Volumn 15, Issue 7, 2007, Pages 1264-1272

  Cherqui, Stephanie ^a   Kingdon, Kenneth M ^a   Thorpe, Camille ^a   Kurian, Sunil M ^a   Salomon, Daniel R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; AMPHIREGULIN; ANGIOGENIC FACTOR; ANGIOPOIETIN LIKE 4 PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BRAIN DERIVED NEUROTROPHIC FACTOR; CADHERIN; CADHERIN H; CALDESMON; CALDESMON 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CATHEPSIN L; ENDOTHELIN 1; FIBRONECTIN; GROWTH FACTOR RECEPTOR; HEPARANASE; INTERLEUKIN 1ALPHA; LENTIVIRUS VECTOR; MACROPHAGE INFLAMMATORY PROTEIN 2; NERVE CELL ADHESION MOLECULE; NEUROPILIN 2; OPIOID GROWTH FACTOR RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VIRUS PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HOST CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; REVASCULARIZATION; SMOOTH MUSCLE FIBER; STEM CELL; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LAMININ; LENTIVIRUS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; STEM CELLS; TRANSGENES;

HUMAN HERPESVIRUS 8;

EID: 34250723250     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300183     Document Type: Article

References (50)

1. Symes, JF, Losordo, DW, Vale, PR, Lathi, KG, Esakof, DD, Mayskiy, M et al. (1999). Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68: 830-836, discussion 836-837.
2. Losordo, DW, Vale, PR, Hendel, RC, Milliken, CE, Fortuin, FD, Cummings, N et al. (2002). Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105: 2012-2018.
3. Laham, RJ, Selike, FW, Edelman, ER, Pearlman, JD, Ware, JA, Brown, DL et al. (1999). Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100: 1865-1871.
4. Cao, R, Brakenhielm, E, Pawliuk, R, Wariaro, D, Post MJ, Wahlberg, E et al. (2003). Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9: 604-613.
5. Tateishi-Yuyama, E, Matsubara, H, Murohara, T, Ikeda, U, Shintani, S, Masaki, H et al. (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427-435.
6. Assmus, B, Schachinger, V, Teupe, C, Britten, M, Lehmann, R, Dobert, N et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017.
7. Seiler, C, Pohl, T, Wustmann, K, Hutter, D, Nicolet, PA, Windecker, S et al. (2001). Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: A randomized, double-blind, placebo-controlled study. Circulation 104: 2012-2017.
8. Boshoff, C, Endo, Y, Collins, PD, Takeuchi, Y, Reeves, JD, Schweickart VL et al. (1997). Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278: 290-294.
9. Kledal, TN, Rosenkilde, MM, Coulin, F, Simmons, G, Johnsen, AH, Alouani, S et al. (1997). A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277: 1656-1659.
10. Murphy, PM (2001). Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2: 116-122.
11. Sozzani, S, Luini, W, Bianchi, G, Allavena, P, Wells, TN, Napolitano, M et al. (1998). The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92: 4036-4039.
12. Dairaghi, DJ, Fan, RA, McMaster, BE, Hanley, MR and Schall, TJ (1999). HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem 274 21569-21574.
13. Zheng, XX, Sanchez-Fueyo, A, Domening, C and Strom, TB (2003). The balance of deletion and regulation in allograft tolerance. Immunol Rev 196: 75-84.
14. Chen, S, Bacon, KB, Li, L, Garcia, GE, Xia, Y, Lo, D et al. (1998). in vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Fxp Med 188: 193-198.
15. DeBruyne, LA, Li, K, Bishop, DK and Bromberg, JS (2000). Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity. Gene Ther 7: 575-582.
16. Boshoff, C and Weiss, RA (1997). Aetiology of Kaposi's sarcoma: Current understanding and implications for therapy. Mol Med Today 3: 488-494.
17. Cherqui, S, Kurian, SM, Schussler, O, Hewel, JA, Yates, JR 3rd and Salomon, DR (2006). Isolation and angiogenesis by endothelial progenitors in the fetal liver. Stem Cells 24: 44-54.
18. Hanazono, Y, Terao, K and Ozawa, K (2001). Gene transfer into nonhuman primate hematopoietic stem cells: Implications for gene therapy. Stem Cells 19: 12-23.
19. Cui, Y, Golob, J, Kelleher, E, Ye, Z, Pardoll, D and Cheng, L (2002). Targeting transgene expression to antigen-presenting cells derived from lentivirus-transcluced engrafting human hematopoietic stem/progenitor cells. Blood 99: 399-408.
20. Szilvassy, SJ, Weller, KP, Lin, W, Sharma, AK, Ho, AS, Tsukamoto, A et al. (1996). Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells. Blood 87 4618-4628.
21. Stamm, C, Liebold, A, Steinhoff, G and Strunk D (2006). Stem cell therapy for ischemic heart disease: Beginning or end of the road? Cell Transplant 15 (suppl. 1): S47-S56.
22. Springer, ML, Chen, AS, Kraft, PE, Bednarski, M and Blau, HM (1998). VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol Cell 2: 549-558.
23. Carmeliet P (2000). VEGF gene therapy: Stimulating angiogenesis or angioma-genesis? Nat Med 6: 1102-1103.
24. Weis, SM and Cheresh, DA (2005). Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437: 497-504.
25. Ferrara, N and Alitalo, K (1999). Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5: 1359-1364.
26. Pettersson, A, Nagy, JA, Brown, LF, Sundberg, C, Morgan, E, jungles, S et al. (2000). Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80: 99-115.
27. Akerman, ME, Pilch, J, Peters, D and Ruoslahti, E (2005). Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. Proc Natl Acad Sci USA 102: 2040-2045.
28. Su, Y, Cui, Z, Li, Z and Block, ER (2006). Calpain-2 regulation of VEGF-mediated angiogenesis. FASEB J 20: 1443-1451.
29. Shoji, T, Koyama, H, Morioka, T, Tanaka, S, Kizu, A, Motoyama, K et al. (2006). Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes 55: 2245-2255.
30. Carlsson, PO, Palm, F and Mattsson, G (2002). Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab 87: 5418-5423.
31. Fontaine, MJ and Fan, W (2003). Islet cell transplantation as a cure for insulin dependent diabetes: Current improvements in preserving islet cell mass and function. Hepatobiliary Pancreat Dis Int 2: 170-179.
32. Bais, C, Santomasso, B, Coso, O, Arvanitakis, L, Raaka, EG, Gutkind, JS et al. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86-89.
33. Sodhi, A, Montaner, S, Patel, V, Zohar, M, Bais, C, Mesri, EA et al. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endotheliall growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1 alpha. Cancer Res 60. 4873-4880.
34. Flore, O, Rafii, S, Ely, S, O'Leary, JJ, Hyjek, EM and Cesarman, E (1998). Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394: 588-592.
35. Moses, AV, Jarvis, MA, Raggo, C, Bell, YC, Ruhl, R, Luukkonen, BG et al. (2002). Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J Virol 76: 8383-8399.
36. Okazaki, T, Ebihara, S, Takahashi, H, Asada, M, Kanda, A and Sasaki, H (2005). Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis. J Immunol 174: 7531-7538.
37. Tangkeangsirisin, W and Serrero, G (2004). PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 25: 1587-1592.
38. Muller, MM, Singer, BB, Klaile, E, Obrink, B and Lucka, L (2005). Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 105: 3925-3934.
39. Salven, P, Hattori, K, Heissig, B and Rafii, S (2002). Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J 16: 1471-1473.
40. Magnusson, MK and Mosher, DF (1998). Fibronectin: Structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 18: 1363-1370.
41. Billings, PC, Whitbeck JC, Adams, CS, Abrams, WR, Cohen, AJ, Engelsberg, BN et al. (2002). The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J Biol Chem 277: 28003-28009.
42. O'Brien, ER, Bennett, KL, Garvin, MR, Zderic, TW, Hinohara, T, Simpson, JB et al. (1996). Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. Arterioscler Thromb Vasc Biol 16: 576-584.
43. Boudreau, N, Turley, E and Rabinovitch, M (1991). Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev Biol 143 235-247.
44. Leung, WC, Lawrie, A, Demaries, S, Massaeli, H, Burry, A, Yablonsky, S et al. (2004). Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration. Circ Res 95: 179-186.
45. Arbiser, IL, Moses, MA, Fernandez, CA, Ghiso, N, Cao, Y, Klauber, N et al. (1997). Oncogenic H-ras stimulates tumor angiogeneis by two distinct pathways. Proc Natl Acad Sd USA 94: 861-866.
46. Naldini, L, Blomer, U, Gallay, P, Ory, D, Mulligan, R, Gage, FH et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
47. Miyoshi, H, Blomer, U, Takahashi, M, Gage, FH and Verma, IM (1998). Development of a self-inactivating lentivirus vector. J Virol 72: 8150-8157.
48. Boshoff, C, Gao, SJ, Healy, LE, Matthews, S, Thomas, AJ, Coignet, L et al. (1998). Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 91 1671-1679.
49. Naldini, L, Blomer, U, Gage, FH, Trono, D and Verma, IM (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93: 11382-11388.
50. Bolstad, BM, Irizarry, RA, Astrand, M and Speed, TP (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.